These findings suggest that S1P signaling contributes to cell proliferation and survival in ER-positive BC, and FTY720 appears to be effective in increasing effectiveness of treatment for ER-positive BC, including hormone therapy-resistant types, by blocking the downstream signaling pathway of non-genomic action of estradiol (Figure 5). The gene discussed is MBTPS1; the disease is breast cancer.